Given what we do understand about the potential action on cellular signaling pathways this could pose serious risk
For a 75 to 90kg adult, that translates roughly to 190 to 900mcg daily, which brackets the 200 to 500mcg range being used in practice
GHK-Cu has been studied for its potential relevance to connective tissue and extracellular matrix regulation in cell and tissue models, while TB-500 and BPC-157 have been investigated in preclinical systems involving soft tissue, tendon and ligament models, and angiogenesis related signaling
Biological Activity Cagrilintide and semaglutide, when co-administered, produce synergistic reductions in bodyweight (up to ~1517% over 2032 weeks in clinical trials) and significant improvements in glycemic parameters, including HbA1c and fasting glucose
BPC-157 is currently classified as an experimental compound for research use only